Jul 17 2013
Avantor™ Performance Materials, a global manufacturer of performance materials and chemicals, today announced it has expanded its arrangement with VWR International, LLC for distribution of its pharmaceutical production chemicals portfolio in the Europe, Middle East and Africa (EMEA) region.
VWR is a global solutions provider of laboratory supplies, equipment and services, with worldwide sales in excess of $4.1 billion in 2012.
Avantor is a global resource for biopharmaceutical and pharmaceutical manufacturers worldwide -- supplying the highest quality ingredients, processing agents, bio buffers, nutrients and excipients, from discovery to full-scale production.
“The expansion of our access to VWR’s global distribution capabilities and infrastructure allows both companies to significantly enhance their sales and marketing presence in the region,” said Paul Smaltz, Executive Vice President of Pharmaceuticals for Avantor.
“We anticipate strong sales growth in the biopharmaceutical and pharmaceutical industry in the EMEA region over the next several years, combined with an enhanced ability to better serve the customer needs, through VWR’s supply chain capabilities,” Smaltz added.
“VWR is very pleased to expand its current arrangement with Avantor to support our customers with its quality products. This, combined with VWR’s 160 years of experience, will bring significant value to our customers and support their production needs,” said Manuel Brocke-Benz, VWR’s President and CEO.
Visit www.avantormaterials.com or www.twitter.com/avantor_news for more information.